Efficacy and safety of 1-hour infusion of recombinant human atrial natriuretic peptide in patients with acute decompensated heart failure: a phase III, randomized, double-blind, placebo-controlled, multicenter trial
Wang Pengbo,Wang Guo-Gan,Li Yi-Shi,et al.Efficacy and safety of 1-hour infusion of recombinant human atrial natriuretic peptide in patients with acute decompensated heart failure: a phase III, randomized, double-blind, placebo-controlled, multicenter trial[J].JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY.2015,66(16):C208-C208.doi:10.1016/j.jacc.2015.06.796.
APA:
Wang, Pengbo,Wang, Guo-Gan,Li, Yi-Shi,Liu, Wen-Xian,Bai, Shu-Gong...&Wang, Si-Jia.(2015).Efficacy and safety of 1-hour infusion of recombinant human atrial natriuretic peptide in patients with acute decompensated heart failure: a phase III, randomized, double-blind, placebo-controlled, multicenter trial.JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,66,(16)
MLA:
Wang, Pengbo,et al."Efficacy and safety of 1-hour infusion of recombinant human atrial natriuretic peptide in patients with acute decompensated heart failure: a phase III, randomized, double-blind, placebo-controlled, multicenter trial".JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 66..16(2015):C208-C208